Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy

    Diabetes, Obesity and Metabolism Date published:

  • A Trial of Extending Hemodialysis Hours and Quality of Life

    Journal of the American Society of Nephrology Date published:

  • Comparison of exposure response relationship of atrasentan between N orth A merican and A sian populations

    Diabetes, Obesity and Metabolism Date published:

  • Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal ( CANVAS-R ): A randomized, placebo-controlled trial

    Diabetes, Obesity and Metabolism Date published:

  • CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk

    Date published:

  • EFFECTS OF EMPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME (R) TRIAL

    Date published:

  • EFFECTS OF EMPAGLIFLOZIN ON RENAL OUTCOMES ACROSS KDIGO RISK CATEGORIES: RESULTS FROM THE EMPA-REG OUTCOME (R) TRIAL

    Date published:

  • Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis

    American Journal of Kidney Diseases Date published:

  • Review: Revascularization and medical treatment may be similar in atherosclerotic renal artery stenosis

    Annals of Internal Medicine Date published:

  • Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Kidney International Date published:

  • Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis

    BMJ Date published:

  • A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension

    The Lancet Date published:

  • Knowing what we do not know: statin therapy in advanced chronic kidney disease

    The Lancet Diabetes & Endocrinology Date published:

  • The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis

    American Journal of Kidney Diseases Date published:

  • The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis

    American Journal of Kidney Diseases Date published:

  • Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects

    Journal of the American Society of Nephrology Date published: